Garber et al. claimed that the presence of elevated anti-TPO titers in patients with subclinical hypothyroidism helped to predict progression to overt hypothyroidism—4.3% per year with anti-TPO versus 2.6% per year without elevated anti-TPO titers [6]. The gene discussed is TPO; the disease is hypothyroidism.